Synopsis of recent research by authors named "Chengming Qu"
- Chengming Qu's recent research focuses on innovative therapeutic strategies targeting liver regeneration and tumor microenvironments, emphasizing the role of extracellular vesicles and engineered bacteria in enhancing treatment efficacy for liver diseases and various cancers.
- Significant findings include the promotion of liver regeneration in mice through β-sitosterol-enriched hepatic extracellular vesicles, as well as the development of nanobody-engineered biohybrid bacteria that induce robust anti-tumor immunity against gastrointestinal cancers.
- Qu's work also explores the mechanisms of resistance in hepatocellular carcinoma (HCC) to immune checkpoint therapy via transcriptomic and metabolomic analyses, along with advancements in photodynamic therapy techniques targeting pancreatic cancer microenvironments to improve immunotherapy outcomes.
